MAPK3 is a common target for T2DM (Maradesha et al., 2023), and evidence has shown that overactivation of MAPK3 can lead to insulin sensitivity impairment, while MAPK3 knockout can undo insulin resistance (Jiao et al., 2013). This evidence concerns the gene MAPK3 and type 2 diabetes mellitus.